Supplementary Figure S1 . Relationships between sleep duration and outcomes*. *Plots represent the adjusted means [adjusted for age, sex, BMI (except when assessing BMI outcome), and study site (in CHS; MESA)] (dots) and standard deviations (bars) of selected outcomes by sleep duration in hours categorized as 4, 5, 6, 7, 8 , and 9 h. Sample size varied by outcome: glycemic traits [4h (n =139), 5h (n =549), 6h (n =2,209), 7h (n =5,778), 8h (n =5,428), 9h (n =1,313)]; anthropometric and lipid traits [4h (n =144), 5h (n =563), 6h (n =2,244), 7h (n =5,817), 8h (n =5,469), 9h (n =1,345)].
Supplementary Figure S2 . Forest plots for the interaction term between: (A) CHO intake and MTNR1B-rs1387153 for FG; (B) MUFA intake and MTNR1B-rs1387153 for FG; (C) total fat intake and NR1D1-rs2314339 for ln-HOMA-IR; (D) SFA intake and NR1D1-rs2314339 for BMI; (E) sleep duration and CRY2-rs11605924 for HDL-C; (F) short sleep duration (<7 h) and MTNR1B-rs1381753 for BMI; and (G) long sleep duration (≥9 h) and MTNR1B-rs1381753 for BMI. The squares represent the point estimate of the association; their size represents the number of participants in a given cohort relative to others presented; the bars represent the 95% confidence interval of the point estimate.
Supplementary Figure S3 . Plots of meta-analyzed interactions for: (A) CHO intake and MTNR1B-rs1387153 for FG*; and (B) sleep duration (continuous) and CRY2-rs11605924 for HDL-C † . Life Style, and Genetic Determinants of Obesity and Metabolic Syndrome (DILGOM) Finland DILGOM1 (DIetary, Lifestyle and Genetic factors on the development of Obesity and Metabolic syndrome 1) Study is a population-based longitudinal study designed to examine five main areas related to the development of obesity and metabolic syndrome: lifestyle factors, psychosocial factors, metabolism and hormonal factors, exposure to environmental pollutants and genetics. The study population consists of 5,024 men and women who participated in the DILGOM baseline study in 2007.
The study protocol includes a questionnaire on lifestyle and psychosocial factors, a validated food frequency questionnaire, measures and blood samples. From these individuals, genotype data was available for 3,792 subjects from FINRISK 2007 population cohort excluding people from Helsinki area. The study was approved by the Ethics Committee of Helsinki and Uusimaa Hospital District.
The study was supported by the Academy of Finland (136635, 136895 and 263836 
USA
The original study population consisted of 1,328 men and women from 148 families consisting of a mix of familial relationships including parent-offspring (N=614), siblings (N=667), grandparent-grandchild (N=89), avuncular (N=617), half-sibling (N=22), grand avuncular (N=69), half avuncular (N=23), first cousins (N=268), half grand avuncular (N=12), 1st cousin once removed (N=81), half 1st cousin (N=11), half 1st cousin once removed (N=4) and 2nd cousin (N=1) relationships. All participants were of European descent recruited in Minneapolis, Minnesota, and Salt Lake City, Utah. The primary aim of the GOLDN study was to characterize the role of genetic and dietary factors on an individual's response to both a high-fat meal challenge and fenofibrate intervention. Briefly, the study protocol consisted of an initial screening visit (visit 0), during which participants were asked to discontinue the use of lipid lowering drugs and over-the-counter medication that could affect lipid levels. Approximately 4 to 8 weeks later, baseline blood chemistries were measured (visit 1). A day later (during visit 2), participants' fasting (8-hour fast) blood samples were collected and the Diet History Questionnaire administered. Anthropometric measures (height and weight) were collected at this time. The final sample consisted only of those willing to undergo the high-fat meal protocol; N=1,036 individuals), and had genotype data after exclusions (N=818). The protocol was approved by the Institutional Review Boards at the University of Minnesota, University of Utah, Tufts University/New England Medical Center and the University of Alabama at Birmingham. Written informed consent was obtained from all participants.
We are grateful to the staff of the GOLDN study for the assistance in data collection and management. This study was funded by NHLBI grant number U01HL072524. GOYA MALE
Denmark
The ADIGEN study is derived from the initial draftboard medical examination (baseline) of men (N=400,975) aged (19-22 years) that took place between in Copenhagen and surrounding areas of Denmark. N=362,200 (90.3%) men were further investigated and divided into obese (BMI≥31kg/m2) cases (N=1930) and a random cohort (1% of 362,200; N=3601) forming a control group. These were then followed up three times as part of Copenhagen city heart study 2 (CCHS2(1981 2 (CCHS2( -1983 : Obese=965, control= 1134 participated), Copenhagen city heart study 3 (CCHS3(1992 3 (CCHS3( -1994 : Obese=795, controls=920 participated) which was the GWAS stage and finally the fourth visit was the ADIGEN ((1998-2000) Obese=234, controls=323 participated) stage. The DNA was available at the CCHS3 stage whereas the valid dietary information and biochemical data were collected at the ADIGEN stage along with the consent to share genetic data for the current analysis.
This study was conducted as part of the activities of the Gene-diet Interactions in Obesity project (GENDINOB, www.gendinob.dk) and the MRC centre for Causal Analyses in Translational Epidemiology (MRC CAiTE). We thank the staff of the Copenhagen City Heart Study for their skillful examination of the study subjects in collection of baseline and follow-up data. 
Italy
InCHIANTI is a population-based study designed to evaluate the factors that influence mobility in older people in the Chianti region of Tuscany, Italy. A total of 1,616 residents were selected from the population registry of Greve (a rural area: 11,709 residents with 19.3% of the population greater than 65 years of age), and Bagno a Ripoli (Antella village near Florence; 4,704 inhabitants, with 20.3% greater than 65 years of age). The participation rate was 90% (n=1453), and the participants ranged between 21-102 years of age. For the present study, 912 adults with available DNA, sleep duration data, and who provided complete dietary information were eligible for the current study. 
Invecchiare

Denmark
The Inter99 study (N=6,089, aged 30-60 years) is a Danish population-based, non-pharmacological intervention study for the prevention of ischemic heart disease conducted at the Research Centre for Prevention and Health (RCPH) in Glostrup, Copenhagen (ClinicalTrials.gov ID-no: NCT00289237, www.inter99.dk). The study was approved by the Scientific Ethics Committee of the Capital Region of Denmark (KA-98155) and all participants provided written informed consent. The Inter99 study was initiated by T. Jørgensen (principal investigator), K. Borch-Johnsen (co-principal investigator), H. Ibsen and T.F. Thomsen. The Steering Committee comprises of Torben Jørgensen and Charlotta Pisinger.
Multi-Ethnic Study of Atherosclerosis (MESA)
USA
The Multi-Ethnic Study of Atherosclerosis (MESA) is a study of the characteristics of subclinical cardiovascular disease (disease detected non-invasively before it has produced clinical signs and symptoms) and the risk factors that predict progression to clinically overt cardiovascular disease or progression of the subclinical disease. MESA researchers study a diverse, population-based sample of 6,814 men and women asymptomatic at baseline aged 45-84 (38 percent of the recruited participants are white, 28 percent African-American, 22 percent Hispanic, and 12 percent Asian, predominantly of Chinese descent). Participants were recruited from six field centers across the United States: Wake Forest University, Columbia University, Johns Hopkins University, University of Minnesota, Northwestern University and University of California -Los Angeles. For the current study, data from Exam 5, from 2,028 individuals with completed diet questionnaires, have sleep duration data, and genotypes were available for analysis.
The Multi-Ethnic Study of Atherosclerosis (MESA) is conducted and supported by contracts N01-HC-95159, N01-HC-95160, N01-HC-95161, N01-HC-95162, N01-HC-95163, N01-HC-95164, N01-HC-95165, N01-HC-95166, N01-HC-95167, N01-HC-95168, and N01-HC-95169 and RR-024156 from the National Heart, Lung, and Blood Institute (NHLBI 
Greece
The Hellenic Study of Interactions between SNPs and Eating in Atherosclerosis Susceptibility (THISEAS) study is a case-control study designed to investigate the association between genetic and lifestyle environmental factors and the risk of coronary artery disease in men and women aged >25 yrs. The control group consists of individuals with no history of cardiovascular disease, while cases are individuals with coronary artery disease. Hematological, biochemical and anthropometric measurements were conducted to all participants. Dietary assessment and physical activity data were collected through face-to-face interview by well-trained scientists. Metabochip was used for DNA analysis. Exclusion criteria for the control group were history of cardiovascular disease, cancer and/ or other inflammatory disease. The population for the present analysis was comprised of 420 subjects with phenotype, genotype, sleep duration data, and dietary data available. In this study the dietary intake was assessed with an estimated seven days dietary record method. The National Food Agency previously validated the method for reported protein intake with the 24-hr urinary nitrogen method and found a general 10% under reporting of protein intake; no analyses of misreporting of protein intake in relation to weight status was included. Participants were carefully instructed to fill in dietary records for 7 consecutive days. The preprinted questionnaires were chronologically divided into sections of food consumed for every meal and in-between snacks. The preprinted options of food items, dishes and beverages commonly consumed were complimented by an open answer option. Portion sizes were given in common household measures, but specific types of foods (rice, pasta, vegetables) or meals (mixed dish, mixed salad, raw food) were quantified using photos. Furthermore participants completed an additional questionnaire with details on use of household fats, milk, cream and sugar in coffee. Diet data was computerized twice and any discrepancy was adjusted. Diet was assessed with a validated, self-administered 128-item FFQ. The FFQ was designed to assess the ordinary diet over the previous 12 mo. The subjects were asked to indicate the average intake frequency of each food item and mixed dish presented as 12 subgroups, eg, dairy products and vegetables. The 9 possible frequency categories ranged from never or seldom to 6 times/d. The portion sizes were fixed, eg, a glass or a slice of bread. Subjects were excluded if their FFQ had >9 blank food items or if their calculated energy intake was <650 or >6100 kcal/d, corresponding to 0.5% at each end of the selfreported daily energy intake scale. Dietary data were collected using a 131-item food frequency questionnaire, selfadministered and checked by a nurse. Participants were asked to report their food consumption during the previous 12 months. The questionnaire had fixed portion sizes and 9 response categories from "never or rarely" to "6 or more times per day". The average daily intakes of nutrients and food groups were calculated by the national food composition database, Fineli, maintained by the National Institute for Health and Welfare, Finland. Sleep duration was defined as the response to the question, "How many hours of sleep do you usually get per day?" Original answering options were the following: 1 = 5 hours or less, 2 = 6 hours, 3 = 6.5 hours, 4 = 7 hours, 5 = 7.5 hours, 6 = 8 hours, 7 = 8.5 hours, 8 = 9 hours, 9 = 9.5 hours, 10 = 10 hours or more. "Five hours or less" and "10 hours or more" were treated as 5 and 10, respectively, otherwise the reported sleeping hours were used , so the range for sleep duration was from 5 to 10 hours. 
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